Global mRNA Synthesis Raw Material Market 2024-2028

Publisher TechNavio

Published Mar 14, 2024

Length 170 Pages

SKU # INF18655876

Description

Global MRNA Synthesis Raw Material Market 2024-2028

The mRNA synthesis raw material market is forecasted to grow by USD 776.45 mn during 2023-2028, accelerating at a CAGR of 4.93% during the forecast period. The report on the mRNA synthesis raw material market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic and infectious diseases, advancements in mRNA technology, and the advantages of mRNA vaccines.

Technavio's MRNA synthesis raw material market is segmented as below:

By Application

Vaccine production
Therapeutics production
Others

By End-user

Biopharmaceutical and pharmaceutical companies
CROs and CMOs
Academic and research institutions

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the collaborations in biotechnology and manufacturing processes related to mRNA synthesis as one of the prime reasons driving the mRNA synthesis raw material market growth during the next few years. Also, growing demand for sustainable and environmentally friendly raw materials and increasing R and D investments by pharmaceutical and biopharmaceutical companies will lead to sizable demand in the market.

The report on the MRNA synthesis raw material market covers the following areas:

mRNA synthesis raw material market sizing
mRNA synthesis raw material market forecast
mRNA synthesis raw material market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mRNA synthesis raw material market vendors that include Bayer AG, BioNTech SE, BOCSCI Inc., CELONIC Group, Corden Pharma International GmbH, Creative Biolabs, CureVac AG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HONGENE, Jena Bioscience GmbH, Lonza Group Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, New England Biolabs Inc., Pfizer Inc., Promega Corp., Samsung Electronics Co. Ltd., Thermo Fisher Scientific Inc., and Yeasen Biotechnology Co. Ltd.. Also, the mRNA synthesis raw material market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global mRNA synthesis raw material market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global mrna synthesis raw material market 2018 - 2022 ($ million); 4.2 Application Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 End-user Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2023-2028 (%); Exhibit 31: Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 Vaccine production - Market size and forecast 2023-2028; Exhibit 34: Chart on Vaccine production - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Vaccine production - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Vaccine production - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Vaccine production - Year-over-year growth 2023-2028 (%); 6.4 Therapeutics production - Market size and forecast 2023-2028; Exhibit 38: Chart on Therapeutics production - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Therapeutics production - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Therapeutics production - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Therapeutics production - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Application; Exhibit 46: Market opportunity by Application ($ million); Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 48: Chart on End-user - Market share 2023-2028 (%); Exhibit 49: Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Exhibit 50: Chart on Comparison by End-user; Exhibit 51: Data Table on Comparison by End-user; 7.3 Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028; Exhibit 52: Chart on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%); 7.4 CROs and CMOs - Market size and forecast 2023-2028; Exhibit 56: Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%); 7.5 Academic and research institutions - Market size and forecast 2023-2028; Exhibit 60: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by End-user; Exhibit 64: Market opportunity by End-user ($ million); Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 BioNTech SE; Exhibit 115: BioNTech SE - Overview; Exhibit 116: BioNTech SE - Product / Service; Exhibit 117: BioNTech SE - Key offerings; 12.4 BOCSCI Inc.; Exhibit 118: BOCSCI Inc. - Overview; Exhibit 119: BOCSCI Inc. - Product / Service; Exhibit 120: BOCSCI Inc. - Key offerings; 12.5 Creative Biolabs; Exhibit 121: Creative Biolabs - Overview; Exhibit 122: Creative Biolabs - Product / Service; Exhibit 123: Creative Biolabs - Key offerings; 12.6 CureVac AG; Exhibit 124: CureVac AG - Overview; Exhibit 125: CureVac AG - Product / Service; Exhibit 126: CureVac AG - Key offerings; 12.7 F. Hoffmann La Roche Ltd.; Exhibit 127: F. Hoffmann La Roche Ltd. - Overview; Exhibit 128: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 129: F. Hoffmann La Roche Ltd. - Key news; Exhibit 130: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 131: F. Hoffmann La Roche Ltd. - Segment focus; 12.8 HONGENE; Exhibit 132: HONGENE - Overview; Exhibit 133: HONGENE - Product / Service; Exhibit 134: HONGENE - Key offerings; 12.9 Jena Bioscience GmbH; Exhibit 135: Jena Bioscience GmbH - Overview; Exhibit 136: Jena Bioscience GmbH - Product / Service; Exhibit 137: Jena Bioscience GmbH - Key offerings; 12.10 Lonza Group Ltd.; Exhibit 138: Lonza Group Ltd. - Overview; Exhibit 139: Lonza Group Ltd. - Business segments; Exhibit 140: Lonza Group Ltd. - Key news; Exhibit 141: Lonza Group Ltd. - Key offerings; Exhibit 142: Lonza Group Ltd. - Segment focus; 12.11 Maravai LifeSciences Holdings Inc.; Exhibit 143: Maravai LifeSciences Holdings Inc. - Overview; Exhibit 144: Maravai LifeSciences Holdings Inc. - Business segments; Exhibit 145: Maravai LifeSciences Holdings Inc. - Key offerings; Exhibit 146: Maravai LifeSciences Holdings Inc. - Segment focus; 12.12 Merck KGaA; Exhibit 147: Merck KGaA - Overview; Exhibit 148: Merck KGaA - Business segments; Exhibit 149: Merck KGaA - Key news; Exhibit 150: Merck KGaA - Key offerings; Exhibit 151: Merck KGaA - Segment focus; 12.13 New England Biolabs Inc.; Exhibit 152: New England Biolabs Inc. - Overview; Exhibit 153: New England Biolabs Inc. - Product / Service; Exhibit 154: New England Biolabs Inc. - Key news; Exhibit 155: New England Biolabs Inc. - Key offerings; 12.14 Pfizer Inc.; Exhibit 156: Pfizer Inc. - Overview; Exhibit 157: Pfizer Inc. - Product / Service; Exhibit 158: Pfizer Inc. - Key news; Exhibit 159: Pfizer Inc. - Key offerings; 12.15 Promega Corp.; Exhibit 160: Promega Corp. - Overview; Exhibit 161: Promega Corp. - Product / Service; Exhibit 162: Promega Corp. - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Exhibit 163: Thermo Fisher Scientific Inc. - Overview; Exhibit 164: Thermo Fisher Scientific Inc. - Business segments; Exhibit 165: Thermo Fisher Scientific Inc. - Key news; Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Yeasen Biotechnology Co. Ltd.; Exhibit 168: Yeasen Biotechnology Co. Ltd. - Overview; Exhibit 169: Yeasen Biotechnology Co. Ltd. - Product / Service; Exhibit 170: Yeasen Biotechnology Co. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 171: Inclusions checklist; Exhibit 172: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 173: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 174: Research methodology; Exhibit 175: Validation techniques employed for market sizing; Exhibit 176: Information sources; 13.5 List of abbreviations; Exhibit 177: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global mrna synthesis raw material market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Application - Market share 2023-2028 (%); Exhibits31: Data Table on Application - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on Vaccine production - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Vaccine production - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Vaccine production - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Vaccine production - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Therapeutics production - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Therapeutics production - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Therapeutics production - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Therapeutics production - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Application ($ million); Exhibits47: Data Table on Market opportunity by Application ($ million); Exhibits48: Chart on End-user - Market share 2023-2028 (%); Exhibits49: Data Table on End-user - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by End-user; Exhibits51: Data Table on Comparison by End-user; Exhibits52: Chart on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Biopharmaceutical and pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Biopharmaceutical and pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%); Exhibits64: Market opportunity by End-user ($ million); Exhibits65: Data Table on Market opportunity by End-user ($ million); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2023 and 2028; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: BioNTech SE - Overview; Exhibits116: BioNTech SE - Product / Service; Exhibits117: BioNTech SE - Key offerings; Exhibits118: BOCSCI Inc. - Overview; Exhibits119: BOCSCI Inc. - Product / Service; Exhibits120: BOCSCI Inc. - Key offerings; Exhibits121: Creative Biolabs - Overview; Exhibits122: Creative Biolabs - Product / Service; Exhibits123: Creative Biolabs - Key offerings; Exhibits124: CureVac AG - Overview; Exhibits125: CureVac AG - Product / Service; Exhibits126: CureVac AG - Key offerings; Exhibits127: F. Hoffmann La Roche Ltd. - Overview; Exhibits128: F. Hoffmann La Roche Ltd. - Business segments; Exhibits129: F. Hoffmann La Roche Ltd. - Key news; Exhibits130: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits131: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits132: HONGENE - Overview; Exhibits133: HONGENE - Product / Service; Exhibits134: HONGENE - Key offerings; Exhibits135: Jena Bioscience GmbH - Overview; Exhibits136: Jena Bioscience GmbH - Product / Service; Exhibits137: Jena Bioscience GmbH - Key offerings; Exhibits138: Lonza Group Ltd. - Overview; Exhibits139: Lonza Group Ltd. - Business segments; Exhibits140: Lonza Group Ltd. - Key news; Exhibits141: Lonza Group Ltd. - Key offerings; Exhibits142: Lonza Group Ltd. - Segment focus; Exhibits143: Maravai LifeSciences Holdings Inc. - Overview; Exhibits144: Maravai LifeSciences Holdings Inc. - Business segments; Exhibits145: Maravai LifeSciences Holdings Inc. - Key offerings; Exhibits146: Maravai LifeSciences Holdings Inc. - Segment focus; Exhibits147: Merck KGaA - Overview; Exhibits148: Merck KGaA - Business segments; Exhibits149: Merck KGaA - Key news; Exhibits150: Merck KGaA - Key offerings; Exhibits151: Merck KGaA - Segment focus; Exhibits152: New England Biolabs Inc. - Overview; Exhibits153: New England Biolabs Inc. - Product / Service; Exhibits154: New England Biolabs Inc. - Key news; Exhibits155: New England Biolabs Inc. - Key offerings; Exhibits156: Pfizer Inc. - Overview; Exhibits157: Pfizer Inc. - Product / Service; Exhibits158: Pfizer Inc. - Key news; Exhibits159: Pfizer Inc. - Key offerings; Exhibits160: Promega Corp. - Overview; Exhibits161: Promega Corp. - Product / Service; Exhibits162: Promega Corp. - Key offerings; Exhibits163: Thermo Fisher Scientific Inc. - Overview; Exhibits164: Thermo Fisher Scientific Inc. - Business segments; Exhibits165: Thermo Fisher Scientific Inc. - Key news; Exhibits166: Thermo Fisher Scientific Inc. - Key offerings; Exhibits167: Thermo Fisher Scientific Inc. - Segment focus; Exhibits168: Yeasen Biotechnology Co. Ltd. - Overview; Exhibits169: Yeasen Biotechnology Co. Ltd. - Product / Service; Exhibits170: Yeasen Biotechnology Co. Ltd. - Key offerings; Exhibits171: Inclusions checklist; Exhibits172: Exclusions checklist; Exhibits173: Currency conversion rates for US$; Exhibits174: Research methodology; Exhibits175: Validation techniques employed for market sizing; Exhibits176: Information sources; Exhibits177: List of abbreviations

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now